Xtant Medical Holdings, Inc. (XTNT)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch XTNT
See up to 3 months of XTNT. The 7-day demo opens the 1M and 3M ranges and puts XTNT on your watchlist.
Start 7-day demoLatest XTNT insider trades
About Xtant Medical Holdings, Inc. (XTNT)
Xtant Medical Holdings, Inc. files with the SEC under CIK 0001453593 and is classified as surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.
XTNT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 8 | 2,585,343 | |
| Tax withholding / forfeiture | 3 | 45,830 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
XTNT insider transactions (Form 4)
2922 Form 4 filings on record, the earliest from Oct 16, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Tyler Lipschultz - Director | Grant or award | Common Stock | 215,517 footnote F1 | $0.00 | - | |
| ||||||
| John K. Bakewell - Director | Grant or award | Common Stock | 215,517 footnote F1 | $0.00 | - | |
| ||||||
| Jonn R. Beeson - Director | Grant or award | Common Stock | 215,517 footnote F1 | $0.00 | - | |
| ||||||
| Abhinav Jain - Director | Grant or award | Common Stock | 215,517 footnote F1 | $0.00 | - | |
| ||||||
| Stavros G. Vizirgianakis - Director | Grant or award | Common Stock | 323,275 footnote F1 | $0.00 | - | |
| ||||||
| Mark A. Schallenberger - Officer | Grant or award | Common Stock | 450,000 footnote F1 | $0.00 | - | |
| Mark A. Schallenberger - Officer | Tax withholding / forfeiture | Common Stock | 7,070 footnote F3 | $0.31 | $2K | |
| ||||||
| Scott C. Neils - Officer | Grant or award | Common Stock | 400,000 footnote F1 | $0.00 | - | |
| Scott C. Neils - Officer | Tax withholding / forfeiture | Common Stock | 28,155 footnote F3 | $0.31 | $9K | |
| ||||||
| Sean E. Browne - Officer | Grant or award | Common Stock | 550,000 footnote F1 | $0.00 | - | |
| Sean E. Browne - Officer | Tax withholding / forfeiture | Common Stock | 10,605 footnote F3 | $0.31 | $3K | |
| ||||||
| Mark A. Schallenberger - Officer | Tax withholding / forfeiture | Common Stock | 7,709 footnote F1 | $0.58 | $4K | |
| ||||||
| Scott C. Neils - Officer | Tax withholding / forfeiture | Common Stock | 8,084 footnote F1 | $0.65 | $5K | |
| ||||||
| Abhinav Jain - Director | Grant or award | Common Stock | 158,228 footnote F1 | $0.00 | - | |
| ||||||
| Jonn R. Beeson - Director | Grant or award | Common Stock | 158,228 footnote F1 | $0.00 | - | |
| ||||||
| Mark A. Schallenberger - Officer | Grant or award | Common Stock | 292,253 footnote F1 | $0.00 | - | |
| Mark A. Schallenberger - Officer | Grant or award | Performance Stock Units (PSUs) | 584,506 footnote F4 | $0.00 | - | |
| ||||||
| Scott C. Neils - Officer | Grant or award | Common Stock | 263,291 footnote F1 | $0.00 | - | |
| Scott C. Neils - Officer | Grant or award | Performance Stock Units (PSUs) | 526,582 footnote F4 | $0.00 | - | |
| ||||||
| Sean E. Browne - Officer | Grant or award | Common Stock | 394,937 footnote F1 | $0.00 | - | |
| Sean E. Browne - Officer | Grant or award | Performance Stock Units (PSUs) | 789,874 footnote F4 | $0.00 | - | |
| ||||||
| Stavros G. Vizirgianakis - Director | Grant or award | Common Stock | 553,797 footnote F1 | $0.00 | - | |
| ||||||
| Tyler Lipschultz - Director | Grant or award | Common Stock | 158,228 footnote F1 | $0.00 | - | |
| ||||||
| John K. Bakewell - Director | Grant or award | Common Stock | 158,228 footnote F1 | $0.00 | - | |
| ||||||
| Sean E. Browne - Officer | Tax withholding / forfeiture | Common Stock | 10,605 | $0.63 | $7K | |
| Scott C. Neils - Officer | Tax withholding / forfeiture | Common Stock | 34,131 | $0.63 | $22K | |
| ORBIMED ADVISORS LLC - 10% Owner | Open-market sale | Common Stock | 56,004,974 | $0.42 | $23.52M | |
| ORBIMED ADVISORS LLC - 10% Owner | Open-market sale | Common Stock | 17,109,618 | $0.42 | $7.19M | |
| Sean E. Browne - Officer | Tax withholding / forfeiture | Common Stock | 105,442 | $0.59 | $62K | |
Item 2.02, 9.01
Item 5.07, 9.01
Item 2.02, 8.01, 9.01
Item 7.01, 8.01, 9.01
XTNT insider trading FAQ
What is the latest insider trade for XTNT?
Xtant Medical Holdings, Inc. (XTNT) had 8 insider filings in the last 90 days, with the most recent on 2026-08-18. The full record for XTNT runs to 22 Form 4 filings, the earliest from 2024-10-16. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying XTNT stock?
No insider purchases of XTNT were filed in the last 90 days.
How many insiders are selling XTNT stock?
No insider sales of XTNT were filed in the last 90 days. 2 sales are on record for this company.
Where can I see XTNT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects XTNT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Tyler Lipschultz view on EDGAR
- - John K. Bakewell view on EDGAR
- - Jonn R. Beeson view on EDGAR
- - Abhinav Jain view on EDGAR
- - Stavros G. Vizirgianakis view on EDGAR
- - Mark A. Schallenberger view on EDGAR
- - Scott C. Neils view on EDGAR
- - Sean E. Browne view on EDGAR
- - Mark A. Schallenberger view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where XTNT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow XTNT with a 7-day demo
- XTNT on your watchlist
- Every XTNT Form 4 filing on record
- Up to 3 months of XTNT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
